JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr® 1 (epinephrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback